Apyx CEO granted 213,948 stock options
Apyx Medical Corp disclosed that Chief Executive Officer Charles D. Goodwin II received a grant of stock options for 213,948 shares of common stock.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Apyx Medical Corp disclosed that Chief Executive Officer Charles D. Goodwin II received a grant of stock options for 213,948 shares of common stock. The options have an exercise price of $4.65 per share, vest ratably over 36 months, and become fully exercisable on the third anniversary of the grant date.
Insider Trade Summary
Grant/Award: 213,948 shares
Grant/Award
1 txn
Insider
Goodwin Charles D. II
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Option to Buy) | 213,948 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Option to Buy) — 213,948 contracts (Direct)
Footnotes (1)
- F1. Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant.
Key Figures
Stock options granted: 213,948 options
Exercise price: $4.65 per share
Underlying shares: 213,948 shares
+3 more
6 metrics
Stock options granted
213,948 options
Grant to CEO on June 11, 2026
Exercise price
$4.65 per share
Stock option strike price
Underlying shares
213,948 shares
Common stock subject to options
Expiration date
June 11, 2036
Option term end
Vesting period
36 months
Ratable vesting until third anniversary
Options held after grant
213,948 options
Total derivative securities following transaction
Key Terms
Stock Option (Option to Buy), Common Stock, exercise price, vesting, +1 more
5 terms
Stock Option (Option to Buy) financial
"security_title: Stock Option (Option to Buy)"
Common Stock financial
"underlying_security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
exercise price financial
"conversion_or_exercise_price: 4.6500"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"shall vest ratably over a thirty six (36) month period"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
derivative securities financial
"derivativeTransactionCount: 1"
Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Apyx Medical (APYX) report in this Form 4 filing?
Apyx Medical reported that CEO Charles D. Goodwin II received a grant of 213,948 stock options. These options relate to common stock and are a derivative security with a defined vesting schedule and exercise terms.
How many stock options did the Apyx Medical (APYX) CEO receive?
The CEO received 213,948 stock options. Each option represents the right to buy one share of Apyx Medical common stock, subject to vesting over time and payment of the stated exercise price when exercised.
What is the exercise price and expiration date of the APYX CEO’s options?
The stock options have an exercise price of $4.65 per share and expire on June 11, 2036. The CEO can exercise vested options any time before this expiration date, subject to company and plan rules.
How do the Apyx Medical (APYX) CEO’s options vest over time?
The options vest ratably over a 36‑month period and become fully vested and exercisable on the third anniversary of the grant date. This means portions vest monthly or periodically until full vesting after three years.
How many derivative securities does the APYX CEO hold after this grant?
After this grant, the CEO holds 213,948 stock options as reported in the filing. This figure reflects the total derivative securities following the transaction, all tied to Apyx Medical’s common stock under the option award.
Is this Apyx Medical (APYX) Form 4 an open‑market stock purchase or sale?
No, the Form 4 reflects a grant of stock options to the CEO, not an open‑market purchase or sale. The transaction is coded as a grant or award acquisition with no price paid at the time of grant.
AI-generated analysis. How Rhea-AI works. Not financial advice.
